The incidence of colorectal cancer in those under the age of 50 has been increasing globally at an alarming rate. Pinpointing the reason remains elusive. Memorial Sloan Kettering has just opened the first center in the world dedicated to research and treatment of the disease as it presents in this demographic.
Despite significant advances in supportive care and improvements in allogeneic hematopoietic stem cell transplantationoutcomes, about one in every three patients succumbs to post-transplant toxicities, half of which are not related to graft-versus-host disease.
Along with Valentine's Day, February marks American Heart Month. MSK’s Vice Chair of Radiation Oncology, Dr Oren Cahlon talks on how his team are making radiation-induced heart disease “a thing of the past” for our breast cancer patients.
Recently published data from Memorial Sloan Kettering shows that most of the guidelines primary care physicians can turn to for advice about appropriate cancer survivorship care are vague and inconsistent, throwing up barriers to effective post cancer care.
There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making.
Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.
Our research shows that most women diagnosed with either breast or gynecologic cancer have concerns about how treatment may affect their sexual and vaginal health. Moreover, they want their healthcare providers to initiate the discussion.